Latest Breaking News On - Saptalis pharmaceuticals - Page 1 : comparemela.com

Antibiotic Collaboration and Licensing Deals Analysis

Dublin, May 07, 2024 (GLOBE NEWSWIRE) The

United kingdomBoston universityUnited statesDana farber cancer instituteSouth australiaUniversity of california los angelesNew south walesTheravance biopharmaChelexa biosciencesZydus cadilaRedhill biopharmaMatinas biopharmaBasilea pharmaceuticaArtizan biosciencesQpex biopharmaMagle chemoswed

Aditxt, Inc (ADTX) to Acquire Appili Therapeutics

Aditxt, Inc (ADTX) to Acquire Appili Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMaryo brienDon cillaAmro albannaFrancisella tularensisRichter hamptonNelson mullins riley scarboroughSaptalis pharmaceuticalsAditxt incBloom burton coDentons canadaUs national institutes of healthAppili special committeeAdivir incWorld health organizationAird berlis

Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc , Developer of a Biodefense Vaccine Funded by the U S Department of Defense (DoD)

Assets include the FDA-approved LIKMEZ™, the ATI-1701 tularemia vaccine defense program that has been awarded a USD $14 million non-dilutive award from the DoD, and the ATI-1801 topical.

United statesDon cillaAmro albannaFrancisella tularensisAditxt incNelson mullins riley scarboroughDentons canadaSaptalis pharmaceuticalsRichter hamptonAppili therapeutics incAird berlisAdivir incWorld health organizationAppili special committeeBloom burton coUs national institutes of health

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

13.02.2024 - FDA approved LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND submission to the FDA Engaging regulatory . Seite 1

United statesDon cillaSaptalis pharmaceuticalsAppili therapeutics incCompany or appiliNova scotiaChief executive officerAppili therapeutics registereda chartPpili therapeutics registereda kursPpili therapeutics registereda aktie

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJenna mcneilCeoappili therapeuticsDon cillaUs air force academyCommunications managerappili therapeuticsInternational accounting standard boardAppili therapeutics incSaptalis pharmaceuticalsCompany or appiliMetronidazole oral suspensionForce academyNova scotiaChief executive officerBiodefense vaccine candidateStrong government